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Abstract 
Background: Intensive care unit (ICU) patients are aging, and older age has been associated with higher mortality 
in ICU. As previous studies have reported that older age was also associated with less intensive treatment, we investi‑
gated the relationship between age, treatment intensity and mortality in medical ICU patients.
Methods: Data were extracted from the administrative database of 18 medical ICUs. Patients with a unique medi‑
cal ICU stay and a Simplified Acute Physiology Score II (without age‑related points) >15 were included. Treatment 
intensity was described with a novel indicator, which is a four‑group classification based upon the most frequent ICU 
procedures. The relationship between age, treatment intensity and hospital mortality was analyzed with the estima‑
tion of standardized mortality ratio in the four groups of treatment intensity.
Results: A total of 23,578 patients, including 3203 patients aged ≥80 years, were analyzed. Hospital mortality 
increased from 13 % for the younger patients (age < 40 years) to 38 % for the older patients (age ≥ 80 years), while 
Simplified Acute Physiology Score II (without age‑related points) increased only from 36 (age < 40 years) to 43 
(age ≥ 80). Hospital mortality increased with age in the four groups of treatment intensity. Standardized mortality 
ratio increased with age among the patients with less intensive treatment but was not associated with age among 
the patients with the highest treatment intensity.
Conclusion: Our results support the fact that the increase in mortality with age among ICU patients is not related to 
an increase in severity. Using a new tool to estimate ICU treatment intensity, our study suggests that mortality of ICU 
patients increases with age whatever the treatment intensity is. Further investigations are required to determinate 
whether this increase in mortality among older ICU patients is related to undertreatment or to a lower efficiency of 
organ support treatment.
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Background
Intensive care unit (ICU) patients are aging as the global 
population does, with, as an example, 13  % of patients 
>80 years among 120,123 ICU patients in a recent study 
from Australia and New Zealand [1]. Management of 
critically ill old patients will be a more and more frequent 
task for physicians in the next decades.
The relationship between age and prognosis of ICU 
patients has been extensively analyzed among the last 
30 years. Older age was associated with a higher mortality 
in large prospective studies [2–5]. Similar findings were 
made in smaller studies investigating the outcome of sub-
groups of patients with various organ failures [6–8].
However, many uncertainties remain because these 
issues are complex and evolving. Indeed, the definition 
of an “elderly patient” is equivocal. The age thresholds 
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used in the literature to consider a patient as an elderly 
one vary from 60 to 80 years [9, 10]. Another pitfall in the 
analysis of the published studies is the increase in the life 
expectancy in the global population during the last dec-
ades. The elderly patients admitted in ICU 20  years ago 
had a lower life expectancy than those admitted now. The 
current validity of previously published studies is ques-
tionable. Another, and probably major, bias in the analysis 
of the impact of age on outcome is the variability of the 
behaviors of the physicians in charge of elderly patients. 
Elderly patients are less admitted in ICU than younger 
critically ill patients [11–13] and may receive less intensive 
treatment [14], and their treatments are more frequently 
withheld [15]. Medical management of elderly critically ill 
patients evolved during the latest decade with increased 
ICU admission and increased ICU caregivers’ workload 
[16]. Data about treatment intensity and age are scarce 
and ambiguous because well-established measurements 
of treatment intensity are still lacking. Therapeutic Inter-
vention Scoring System (TISS-28) [17], OMEGA [18] and 
Nine Equivalents of nursing Manpower use Score (NEMS) 
[19], the most commonly used scores, are derived from 
the TISS score, which was developed as a severity index. 
These scores are validated to measure the ICU staff work-
load and not to evaluate the therapeutic intensity. The 
European Society of Intensive Care Medicine (ESICM) 
defined three levels of care (LOC) to describe the ICUs 
[20]. These ESICM’s LOCs take into account the number 
of organ failure that can be supported in the unit. Such an 
approach is used by the French National Health Insurance 
System to define the level of payment of ICU stays.
For these reasons, we designed the present study to 
describe the relationship between age and outcome 




We analyzed the administrative database of the Assis-
tance Publique—Hôpitaux de Paris. Our institution is 
made of 37 public teaching hospitals and includes 18 
medical ICUs. Medical and administrative data from 
each hospital are merged in a central database. Since 
2004, French intensivists are required to code for sig-
nificant procedures (as defined by the French National 
Health Insurance System) and for Simplified Acute Physi-
ology Score (SAPS2) [2]. Noncoding of these data has a 
negative financial impact upon hospital’s financing. Qual-
ity controls are locally performed to detect over-coding 
and under-coding.
The data collected for each hospital stay include age, 
gender, type and number of the performed procedures, 
the identification and the length of stays in the different 
units of the hospital. Diagnoses and comorbidities were 
coded according to the International Classification of the 
Diseases ICD-10. The diagnosis that required the higher 
resource consumption during the ICU stay was quoted, 
but the admission diagnosis was not specifically identi-
fied. The coding process is regularly updated.
Data are anonymous, and patients with multiple hospi-
tal stays cannot be identified.
Hospital stays with one medical ICU stay and an age-
adjusted SAPS2 > 15 (threshold used in France to sepa-
rate intensive care and intermediate care patients) were 
included in the analysis. Cases with multiple ICU stays 
during the same hospital stay or with unknown SAPS2 
cases were excluded. Period of analysis was 2006–2008 
because the coding process was similar during these 
3 years.
Treatment intensity classification
A treatment intensity indicator was built by an expert 
consensus based on the French National Health Insur-
ance System criteria of level of payment of ICU stays 
(Table 1). The indicator took into account the most fre-
quent procedures: hemodynamic support, respiratory 
support and renal support. Two levels of support were 
defined: low-intense (hemodynamic: use of less than 
8  μg/kg/min of dobutamine or dopamine; respiratory: 
noninvasive ventilation or mechanical ventilation with 
FiO2  <  0.6 and PEEP  <  6  cm H2O) and high-intense 
(hemodynamic: use of more than 8 μg/kg/min of dobu-
tamine or dopamine, or use of epinephrine or nor-
epinephrine; respiratory: mechanical ventilation with 
FiO2 ≥ 0.6 or PEEP ≥ 6 cm H2O; renal: any type of renal 
replacement therapy). A four-group treatment inten-
sity classification was defined according to the number 
and the level of supports: no support (group 0), only one 
low-intense support (group 1), two low-intense supports 
or one high-intense support (group 2) and more intense 
support (group 3).
Statistical analysis
SAPS2 is a prospectively validated severity score [2], 
based upon physiologic data. The score can be converted 
to a probability of hospital mortality [2]. This probability 
of hospital mortality has been widely used to determinate 
standardized mortality ratio (SMR) between observed 
mortality and SAPS2-expected mortality in order to ana-
lyze the performance of ICUs. Fifteen variables, includ-
ing age, are required to calculate SAPS2. Age-adjusted 
SAPS2 is calculated by subtracting the age-related points 
and is commonly used in the literature [21]. Age-adjusted 
SAPS2 was used as an age-independent severity index. 
Standardized mortality ratio (SMR) was calculated using 
SAPS2. Age was analyzed as a continuous, a qualitative 
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(the age categories of the SAPS2 score) and a binary (<80 
or ≥80 years) variable. Quantitative data were presented 
as means and standard deviation (SD). Their variations 
were analyzed using the ANOVA. Qualitative data are 
presented as numbers and percentages. Their variations 
were analyzed using the Chi-square test. Statistical analy-




During the 3-year period of interest, 23,578 stays met the 
inclusion criteria and were analyzed (Fig. 1: flowchart).
Sex ratio was 1.47 (14,023 men/9555 women). Mean 
age was 58.3 years (SD 18.2), and 3203 (13.6 %) patients 
were ≥80 year old. Mean age-adjusted SAPS2 was 41 (SD 
21). Hospital mortality rate was 29.5 %.
Severity and mortality according to the age
Mean age-adjusted SAPS2 increased slightly but signifi-
cantly with age: 36 (SD 18) in <40-year-old patients, 41 
(SD 20) in 40- to 69-year-old patients, 41 (SD 21) in 70- 
to 74-year-old patients, 42 (SD 22) in 75- to 79-year-old 
patients and 43 (SD 22) in patients older than 80  years 
(P  <  .001). Crude hospital mortality increased with age, 
as illustrated in Fig. 2, from 13 % (SD 33) in <40-year-old 
patients, 23 % (SD 42) in 40- to 69-year-old patients, 32 % 
(SD 47) in 75- to 79-year-old patients and 38 (SD 49) in 
patients older than 80 years (P < .001).
Treatment intensity and age
Among the 23,578 patients analyzed, 7297 (31  %) did 
not receive any hemodynamic, ventilator or renal sup-
port (group 0), 2961 (14.6  %) received only one low-
intense support (group 1), 3212 (13.6  %) received two 
low-intense supports or one high-intense support (group 
2) and 10,108 (42.9  %) received more intense support 
(group 3).
Mean age differed slightly but significantly (P  <  .001) 
across the four groups: 58.6 (SD 19.3) years for group 0, 
54.0 (SD 18.7) for group 1, 59.5 (SD 18.2) for group 2 and 
61.3 (SD 16.8) for group 3. The distribution of treatment 
intensity was different (P < 0.001) in the SAPS2 age sub-
groups, as reported in Table 2. The distribution of treat-
ment intensity in the patients aged <80 and ≥80 years is 
reported in Table 3 (P < 0.001).
Treatment intensity, age and mortality
Hospital mortality significantly increased with treatment 
intensity: 10.1 % in group 0, 15.6 % in group 1, 19.3 % in 
group 2 and 50.7 % in group 3 (P < .001).
Hospital mortality significantly increased with age in 
all treatment intensity groups (Table  4; Fig.  3). Patients 
aged ≥80  years had higher mortality than the patients 
aged <80 in the four treatment intensity groups: group 0 
21.3 versus 8.2 % (P <  .001), group 1 45.5 versus 12.6 % 
(P  <  .001), group 2 40.3 versus 15.8  % (P  <  .001) and 
group 3 66.2 % versus 48.2 % (P < .001).
Standardized mortality ratio (SMR) according to age 
and treatment intensity
SMR increased with age among patients of group 0, 
group 1 and group 2 but not in group 3 (Fig. 4). SMR of 
the younger patients was very low in group 0, group 1 
and group 2.
Discussion
This study describes more than 23,000 hospital stays 
including a unique medical ICU admission at the Assis-
tance Publique—Hôpitaux de Paris from January 1, 2006, 
to December 31, 2008. Patients aged ≥80  years were 
involved in more than 3200 stays. Hospital mortality 
increased with age, as previously reported. This increase 
in mortality with age was not related to an increase in 
severity (reflected by age-adjusted SAPS2).
Another point in the study is the use of a novel tool to 
describe treatment intensity by integrating data from the 
administrative database of the largest European hospital 
organization. This indicator was not designed to describe 
severity but to estimate the amount of care delivered to 
the patients. We could establish that mortality increased 
with age whatever the treatment intensity was. Several 
hypotheses should be discussed to explain this fact: (1) 
some differences in treatment allocation with elderly 
patients receiving less sustained intensive treatment, (2) 
different ICU admission policies according to age and 
(3) a decreased efficiency of organ support in elderly 
patients.
Table 1 Treatment intensity indicator
Supports Groups of treatment 
intensity
Low‑intense
 Dobutamine or dopamine  
≤8 µg/kg/min
0: no support
 Noninvasive ventilation 1: one low‑intense support
 Mechanical ventilation with FiO2  
< 0.6 and PEEP < 6 cm H2O
2: two low‑intense supports 
or one high‑intense support
3: more intense support
High‑intense
 Dobutamine/dopamine >8 µg/kg/min, 
epinephrine or norepinephrine
 Mechanical ventilation with FiO2  
≥ 0.6 or PEEP ≥ 6 cm H2O
 Renal replacement therapy
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The first hypothesis cannot be excluded because of the 
lack of data about treatment withdrawal in the admin-
istrative database used in our study. The high mortality 
(more than 20  %) among patients ≥80  years admitted 
in the ICU who did not receive vasopressors, mechani-
cal ventilation or renal replacement is suggestive of “do 
not resuscitate” decision in some of these patients. The 
distribution of treatment intensity was different within 
the different age groups, but the differences seemed to be 
clinically insignificant and reflected mainly the great size 
of the study population. Indeed, the proportion of group 
0 and group 3 were quite similar among patients aged 
≥80 years and <80 years (33.5 and 30.5 % for group 0 and 
43.9 versus 42.7 % for group 3). This result suggests that 
the increase in mortality with age was not, or not only, 
related to a difference of treatment intensity and that 
other explanations should be discussed.
Admission policies had not been investigated specifi-
cally in the present study that analyzed only hospital stays 
of patients admitted once in a medical ICU. Data about 
the patients who were denied ICU admission are lacking. 
No data were available about comorbidities and func-
tional status. However, severity was not related to age, 
suggesting that ICU patients were quite homogenous.
The hypothesis of a decreased efficiency of organ sup-
port in elderly patients is strengthened by the increase 
in mortality with age in the four groups of treatment 
intensity and by the increase in SMR with age in the 
group 0, group 1 and group 2. This hypothesis cannot 
be confirmed because treatment intensity could be inad-
equate in some patients (“do not resuscitate” orders) and 
because the timeline of the treatment was not investi-
gated. Indeed, ICU treatments could be less effective if 
they are delayed [22]. However, the absence of variation 
of SMR according to the age in the patients receiving 
the most intensive treatment (group 3) suggests that the 
efficiency of organ support is not decreased in selected 
elderly patients. Our results are homogenous with a 
recent study, which analyzed the amount of care required 
per survivor in ICU patients. Elderly patients required 
a higher amount of care per survivor than the younger 
patients, except for the most critically ill patients [23]. 
Surgical ICU or burns unit: 
38,825 stays
Medical ICU admission: 
36,002 stays
One medical ICU admission: 
29,656 stays
Several medical ICU 
admissions during the hospital
stay: 
6,346 stays
Unknown  SAPS2: 
 902 stays
Age-adjusted SAPS2  15 :  
5,176 stays
Age-adjusted SAPS2 > 15 
23,578 stays
74,827  
Hospital stays with at
least one ICU 
admission
Fig. 1 Flowchart
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The very low SMR of the younger patients is amazing and 
may be explained by a higher adequacy of level of care 
and by a more liberal admission policy.
The present study faced several difficulties. The first 
difficulty was how to define who the elderly patients are. 
For this reason, age was analyzed by using three differ-
ent approaches: as a continuous variable, as a categorical 
variable (use of the subgroups of the SAPS2 score) and 
Fig. 2 Hospital mortality and age
Table 2 Treatment intensity in the different SAPS2 age subgroups
Comparison of the distributions by the Kruskal–Wallis test P < .001
<40 years [n (%)] 40–59 years [n (%)] 60–69 years [n (%)] 70–74 years [n (%)] 75–79 years [n (%)] ≥80 years [n (%)]
Group 0 1381 (35.6 %) 2298 (29.7 %) 1170 (28.5 %) 643 (28.8 %) 732 (30.1 %) 1073 (33.5 %)
Group 1 776 (20.0 %) 1012 (13.1 %) 445 (10.8 %) 232 (10.4 %) 230 (9.5 %) 266 (8.3 %)
Group 2 520 (13.4 %) 1066 (13.8 %) 546 (13.3 %) 315 (14.1 %) 308 (12.7 %) 457 (14.3 %)
Group 3 1200 (31.0 %) 3351 (43.4 %) 1951 (47.4 %) 1040 (46.6 %) 1159 (47.7 %) 1407 (43.9 %)
Table 3 Treatment intensity in  the patients aged <80 
and ≥80 years
<80 years [n (%)] ≥80 years [n (%)]
Group 0 6624 (30.5 %) 1073 (33.5 %)
Group 1 2695 (13.2 %) 266 (8.3 %)
Group 2 2755 (13.5 %) 457 (14.3 %)
Group 3 8701 (42.7 %) 1407 (43.9 %)
Table 4 Hospital mortality according to the age of the patients in the four groups of treatment intensity















Group 0 738 (10.1 %) 35 (2.5 %) 180 (7.8 %) 105 (9.0 %) 81 (12.6 %) 108 (14.8 %) 229 (21.3 %) <.001
Group 1 461 (15.6 %) 30 (3.9 %) 102 (10.1 %) 83 (18.7 %) 55 (23.7 %) 70 (30.4 %) 121 (45.5 %) <.001
Group 2 619 (19.3 %) 41 (7.9 %) 146 (13.7 %) 100 (18.3 %) 65 (20.6 %) 83 (26.9 %) 184 (40.3 %) <.001
Group 3 5128 (50.7 %) 362 (30.2 %) 1496 (44.6 %) 1056 (54.1 %) 574 (55.2 %) 709 (61.2 %) 931 (66.2 %) <.001
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as a dichotomized variable with an elevated threshold 
(80  years) already used in the literature [1, 14]. Similar 
results were obtained with these three approaches. The 
administrative database used in the present study did 
not procure enough information to describe the elderly 
patients with more precise tools like frailty indexes. 
Another difficulty was the measurement of the treatment 
intensity. The currently used scores, TISS-28, NEMS and 
OMEGA, provide validated measurements of the ICU 
staff workload but have not been designed to estimate 
the treatment intensity. We developed an original and 
simple measurement based on the items selected by the 
French National Health Insurance System to describe the 
intensity of care of ICU patients. We focused on the three 
most common organ supports provided in ICUs: vaso-
pressors, mechanical ventilation and renal replacement. 
Interestingly, these variables are already used in validated 
organ failure scores [24, 25]. None of these organ failure 
scores are implemented in the administrative database 
used in the present study. However, these scores cannot 
help us to better analyze the relationship between sever-
ity and treatment intensity because they are determined 
by both severity and treatment intensity. In the present 
study, we chose to analyze the use of organ supports as 
a marker of treatment intensity and not as a marker of 
severity.
The present study has several limits. First, data have 
been extracted from an administrative database. Cod-
ing accuracy was not controlled specifically for the study. 
In particular, some patients may have been over-treated 
to allow upcoding (for instance, FiO2 61  %, PEEP 7  cm 
H2O) [26, 27]. Data about the number of occurrences 
or the duration of each organ support are also lacking. 
Another limit was the use of hospital mortality as unique 
outcome criterion. Pertinent outcome indicators like 
functional recovery, middle-term mortality and readmis-
sion could not be evaluated. Available data did not allow 
us to take into account comorbidities, frailty and with-
holding/withdrawal of life support. Finally, multiple ICU 
stays during the same hospital stay were excluded from 
Fig. 3 Hospital mortality according to treatment intensity and age
Fig. 4 Relationship between the standardized mortality ratio (SMR = observed mortality/expected mortality) and age in the four groups of treat‑
ment intensity. SMR increased with age in the lower intensity groups, reflecting either inadequate treatment intensity or a lower efficiency of treat‑
ment for the older patients. SMR was not related to age in the highest intensity group, reflecting a similar efficiency of such treatment whatever was 
the age of the patients
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the analysis because patients requiring ICU readmission 
have a higher severity and a higher mortality rate than 
the other ICU patients [28]. About 17.6 % (6346/36,002) 
of ICU stays were excluded for this reason. We could not 
identify the patients who had recurrent hospital stays 
with unique ICU admission during each hospital stay.
In spite of these limits, our findings are valuable for 
several reasons. First, a large sample (>23,000) of hos-
pital stays of ICU has been analyzed, including more 
than 3200 stays involving patients aged ≥80  years. The 
administrative database used in the study is regularly 
controlled to avoid over-coding and missing data. Hos-
pitals are financially encouraged to code for the proce-
dures reflecting the treatment intensity. Data came from 
a high number of medical ICUs. Patients treated with 
different medical strategies had been included, offering 
the opportunity to analyze the relationships between age, 
treatment intensity and mortality. The large number of 
ICUs allowed us to collect data about a huge number of 
patients treated during a 3-year period. The shortness of 
the period of data collection increased the homogeneity 
of the sample and limited the bias related to the decali-
bration of SAPS2 [21].
As a conclusion, the present study describes a new 
tool to estimate ICU treatment intensity and supports 
the fact that mortality of ICU patients increases with 
age whatever the treatment intensity is. Further qualita-
tive longitudinal studies paying attention to the patients’ 
functional capacity and to the medical practices are 
required to better understand the relationship between 
age and mortality of ICU patients.
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